Report Detail

Other Global Prostate Cancer Medicine Market Size, Status and Forecast 2019-2025

  • RnM3461647
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 pages
  • |
  • QYResearch
  • |
  • Other

Global Prostate Cancer Medicine Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 LHRH Antagonists
      • 1.4.3 LHRH Analogs
      • 1.4.4 Antiandrogens
      • 1.4.5 Pipeline Drugs for Hormonal Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Prostate Cancer Medicine Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Prostate Cancer Medicine Market Size
    • 2.2 Prostate Cancer Medicine Growth Trends by Regions
      • 2.2.1 Prostate Cancer Medicine Market Size by Regions (2014-2025)
      • 2.2.2 Prostate Cancer Medicine Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Prostate Cancer Medicine Market Size by Manufacturers
      • 3.1.1 Global Prostate Cancer Medicine Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)
    • 3.2 Prostate Cancer Medicine Key Players Head office and Area Served
    • 3.3 Key Players Prostate Cancer Medicine Product/Solution/Service
    • 3.4 Date of Enter into Prostate Cancer Medicine Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Prostate Cancer Medicine Market Size by Type (2014-2019)
    • 4.2 Global Prostate Cancer Medicine Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Prostate Cancer Medicine Market Size (2014-2019)
    • 5.2 Prostate Cancer Medicine Key Players in United States
    • 5.3 United States Prostate Cancer Medicine Market Size by Type
    • 5.4 United States Prostate Cancer Medicine Market Size by Application

    6 Europe

    • 6.1 Europe Prostate Cancer Medicine Market Size (2014-2019)
    • 6.2 Prostate Cancer Medicine Key Players in Europe
    • 6.3 Europe Prostate Cancer Medicine Market Size by Type
    • 6.4 Europe Prostate Cancer Medicine Market Size by Application

    7 China

    • 7.1 China Prostate Cancer Medicine Market Size (2014-2019)
    • 7.2 Prostate Cancer Medicine Key Players in China
    • 7.3 China Prostate Cancer Medicine Market Size by Type
    • 7.4 China Prostate Cancer Medicine Market Size by Application

    8 Japan

    • 8.1 Japan Prostate Cancer Medicine Market Size (2014-2019)
    • 8.2 Prostate Cancer Medicine Key Players in Japan
    • 8.3 Japan Prostate Cancer Medicine Market Size by Type
    • 8.4 Japan Prostate Cancer Medicine Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Prostate Cancer Medicine Market Size (2014-2019)
    • 9.2 Prostate Cancer Medicine Key Players in Southeast Asia
    • 9.3 Southeast Asia Prostate Cancer Medicine Market Size by Type
    • 9.4 Southeast Asia Prostate Cancer Medicine Market Size by Application

    10 India

    • 10.1 India Prostate Cancer Medicine Market Size (2014-2019)
    • 10.2 Prostate Cancer Medicine Key Players in India
    • 10.3 India Prostate Cancer Medicine Market Size by Type
    • 10.4 India Prostate Cancer Medicine Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Prostate Cancer Medicine Market Size (2014-2019)
    • 11.2 Prostate Cancer Medicine Key Players in Central & South America
    • 11.3 Central & South America Prostate Cancer Medicine Market Size by Type
    • 11.4 Central & South America Prostate Cancer Medicine Market Size by Application

    12 International Players Profiles

    • 12.1 AstraZeneca plc
      • 12.1.1 AstraZeneca plc Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Prostate Cancer Medicine Introduction
      • 12.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2014-2019)
      • 12.1.5 AstraZeneca plc Recent Development
    • 12.2 Active Biotech
      • 12.2.1 Active Biotech Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Prostate Cancer Medicine Introduction
      • 12.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2014-2019)
      • 12.2.5 Active Biotech Recent Development
    • 12.3 Bristol Myers-Squibb
      • 12.3.1 Bristol Myers-Squibb Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Prostate Cancer Medicine Introduction
      • 12.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2014-2019)
      • 12.3.5 Bristol Myers-Squibb Recent Development
    • 12.4 Teva Pharmaceuticals Industries Ltd.
      • 12.4.1 Teva Pharmaceuticals Industries Ltd. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Prostate Cancer Medicine Introduction
      • 12.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2014-2019)
      • 12.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development
    • 12.5 Johnson & Johnson
      • 12.5.1 Johnson & Johnson Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Prostate Cancer Medicine Introduction
      • 12.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2014-2019)
      • 12.5.5 Johnson & Johnson Recent Development
    • 12.6 Pfizer Inc.
      • 12.6.1 Pfizer Inc. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Prostate Cancer Medicine Introduction
      • 12.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2014-2019)
      • 12.6.5 Pfizer Inc. Recent Development
    • 12.7 Bayer AG
      • 12.7.1 Bayer AG Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Prostate Cancer Medicine Introduction
      • 12.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2014-2019)
      • 12.7.5 Bayer AG Recent Development
    • 12.8 Abbott Laboratories
      • 12.8.1 Abbott Laboratories Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Prostate Cancer Medicine Introduction
      • 12.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2014-2019)
      • 12.8.5 Abbott Laboratories Recent Development
    • 12.9 Astellas Pharma Inc.
      • 12.9.1 Astellas Pharma Inc. Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Prostate Cancer Medicine Introduction
      • 12.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2014-2019)
      • 12.9.5 Astellas Pharma Inc. Recent Development
    • 12.10 Roche Holding AG
      • 12.10.1 Roche Holding AG Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Prostate Cancer Medicine Introduction
      • 12.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2014-2019)
      • 12.10.5 Roche Holding AG Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise, ethnicity (African American men), and old age contribute to its occurrence.
      In 2018, the global Prostate Cancer Medicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Prostate Cancer Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Cancer Medicine development in United States, Europe and China.

      The key players covered in this study
      AstraZeneca plc
      Active Biotech
      Bristol Myers-Squibb
      Teva Pharmaceuticals Industries Ltd.
      Johnson & Johnson
      Pfizer Inc.
      Bayer AG
      Abbott Laboratories
      Astellas Pharma Inc.
      Roche Holding AG

      Market segment by Type, the product can be split into
      LHRH Antagonists
      LHRH Analogs
      Antiandrogens
      Pipeline Drugs for Hormonal Therapy

      Market segment by Application, split into
      Hospitals
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Prostate Cancer Medicine status, future forecast, growth opportunity, key market and key players.
      To present the Prostate Cancer Medicine development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Prostate Cancer Medicine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Prostate Cancer Medicine . Industry analysis & Market Report on Prostate Cancer Medicine is a syndicated market report, published as Global Prostate Cancer Medicine Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Prostate Cancer Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,125.01
      4,687.52
      6,250.02
      3,471.71
      5,207.56
      6,943.42
      420,365.40
      630,548.10
      840,730.80
      268,573.11
      402,859.67
      537,146.22
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report